Homologous regions of the alpha subunit of eukaryotic translational initiation factor 2 (eIF2alpha) and the vaccinia virus K3L gene product interact with the same domain within the dsRNA-activated protein kinase (PKR).

The vaccinia virus K3L gene product, pK3, binds to the dsRNA-activated protein kinase, PKR, reducing its ability to interact with and phosphorylate eIF2alpha. On the basis of this characteristic and the homology of pK3 to the N-terminus of eIF2alpha, several laboratories have utilized pK3 to investigate the molecular determinants that specify substrate recognition by PKR. The data presented here demonstrate that the natural substrate, eIF2alpha, also binds to PKR in vitro and interacts with the same or an overlapping domain within PKR. A truncated form of eIF2alpha, representing the N-terminal 123 amino acids and containing the regions of homology to pK3, retains the ability to bind PKR. pK3, eIF2alpha, and the truncated form of eIF2alpha all bind to the C-terminus of PKR containing the catalytic domain, but not to the regulatory N-terminus. Variants of pK3 and eIF2alpha, des-(75-78)-K3L (pK3deltaGYID), and des-(80-83)-eIF2alpha (eIF2alphadeltaGYID), from which the conserved amino acids GYID have been deleted, exhibit a decreased ability to interact with PKR. Similarly, the in vitro binding of pK3, eIF2alpha, and the truncated form of eIF2alpha to PKR can be competed with purified pK3 but not with pK3deltaGYID. In addition, the deletion of GYID from eIF2alpha significantly reduces its ability to be phosphorylated by PKR, demonstrating that PKR recognizes its substrate, at least in part through interaction with sequences remote from the phosphorylation site. In summary, we have shown that the region within PKR that interacts with the pseudosubstrate, pK3, is the same region that interacts with the authentic substrate, eIF2alpha. In addition, we have shown that the N-terminal 123 amino acids of eIF2alpha contains structural elements necessary for recognition by PKR. The results pinpoint the GYID motif, shared between pK3 and eIF2alpha and distant from the phosphorylation site, as being important for the interaction of eIF2alpha with PKR, as well as its phosphorylation.

[1]  J. Silverman,et al.  Regulation of the protein kinase PKR by the vaccinia virus pseudosubstrate inhibitor K3L is dependent on residues conserved between the K3L protein and the PKR substrate eIF2alpha , 1997, Molecular and cellular biology.

[2]  R. Jagus,et al.  Use of vertical slab isoelectric focusing and immunoblotting to evaluate steady-state phosphorylation of eIF2 alpha in cultured cells. , 1997, Methods.

[3]  S. Der,et al.  A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[4]  A. Cuddihy,et al.  Physical association between STAT1 and the interferon‐inducible protein kinase PKR and implications for interferon and double‐stranded RNA signaling pathways , 1997, The EMBO journal.

[5]  B. Williams,et al.  Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF‐1 and NF‐κB , 1997, The EMBO journal.

[6]  Masahiko Hibi,et al.  c-Jun Can Recruit JNK to Phosphorylate Dimerization Partners via Specific Docking Interactions , 1996, Cell.

[7]  T. Soderling,et al.  A structural basis for substrate specificities of protein Ser/Thr kinases: primary sequence preference of casein kinases I and II, NIMA, phosphorylase kinase, calmodulin-dependent kinase II, CDK5, and Erk1 , 1996, Molecular and cellular biology.

[8]  T. Takizawa,et al.  Possible involvement of double-stranded RNA-activated protein kinase in cell death by influenza virus infection , 1996, Journal of virology.

[9]  A. Lau,et al.  An essential role for the interferon-inducible, double-stranded RNA-activated protein kinase PKR in the tumor necrosis factor-induced apoptosis in U937 cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Nahum Sonenberg,et al.  The Kinase Insert Domain of Interferon-induced Protein Kinase PKR Is Required for Activity but Not for Interaction with the Pseudosubstrate K3L* , 1996, The Journal of Biological Chemistry.

[11]  M. Katze,et al.  Interaction of the interferon-induced PKR protein kinase with inhibitory proteins P58IPK and vaccinia virus K3L is mediated by unique domains: implications for kinase regulation , 1996, Molecular and cellular biology.

[12]  R. Wek,et al.  Expression of Vaccinia Virus K3L Protein in Yeast Inhibits Eukaryotic Initiation Factor-2 Kinase GCN2 and the General Amino Acid Control Pathway* , 1996, The Journal of Biological Chemistry.

[13]  V. M. Pain.  Initiation of protein synthesis in eukaryotic cells. , 1996, European journal of biochemistry.

[14]  N. Sonenberg,et al.  Double-stranded-RNA-dependent protein kinase and TAR RNA-binding protein form homo- and heterodimers in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[15]  N. Sonenberg,et al.  Abrogation of translation initiation factor eIF‐2 phosphorylation causes malignant transformation of NIH 3T3 cells. , 1995, The EMBO journal.

[16]  M. Katze,et al.  Molecular Mechanisms Responsible for Malignant Transformation by Regulatory and Catalytic Domain Variants of the Interferon-induced Enzyme RNA-dependent Protein Kinase (*) , 1995, The Journal of Biological Chemistry.

[17]  M. Katze,et al.  Mutants of the RNA-dependent protein kinase (PKR) lacking double-stranded RNA binding domain I can act as transdominant inhibitors and induce malignant transformation , 1995, Molecular and cellular biology.

[18]  C. Proud,et al.  PKR: a new name and new roles. , 1995, Trends in biochemical sciences.

[19]  B. Williams,et al.  The role of the dsRNA-activated kinase, PKR, in signal transduction , 1995 .

[20]  J. Darnell,et al.  Contribution of STAT SH2 groups to specific interferon signaling by the Jak-STAT pathway , 1995, Science.

[21]  D. Faller,et al.  Platelet-derived Growth Factor Signal Transduction through the Interferon-inducible Kinase PKR , 1995, The Journal of Biological Chemistry.

[22]  A. Hinnebusch,et al.  Structural requirements for double-stranded RNA binding, dimerization, and activation of the human eIF-2 alpha kinase DAI in Saccharomyces cerevisiae , 1995, Molecular and cellular biology.

[23]  R. Jagus,et al.  Interleukin 3 stimulates protein synthesis by regulating double-stranded RNA-dependent protein kinase. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[24]  M. Katze,et al.  The 58-kilodalton inhibitor of the interferon-induced double-stranded RNA-activated protein kinase is a tetratricopeptide repeat protein with oncogenic properties. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. B. Lee,et al.  The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis. , 1994, Virology.

[26]  C. Samuel,et al.  Mechanism of interferon action: evidence for intermolecular autophosphorylation and autoactivation of the interferon-induced, RNA-dependent protein kinase PKR , 1993, Journal of virology.

[27]  A. Hovanessian.  Interferon-induced dsRNA-activated protein kinase (PKR)*: antiproliferative, antiviral and antitumoral functions , 1993 .

[28]  M. Mathews.  Viral Evasion of Cellular Defense-Mechanisms - Regulation of the Protein-Kinase Dai by Rna Effectors , 1993 .

[29]  O. Elroy-Stein,et al.  Recombinant vaccinia virus K3L gene product prevents activation of double-stranded RNA-dependent, initiation factor 2 alpha-specific protein kinase. , 1993, The Journal of biological chemistry.

[30]  C. Samuel,et al.  The eIF-2 alpha protein kinases, regulators of translation in eukaryotes from yeasts to humans. , 1993, The Journal of biological chemistry.

[31]  R. Rhoads.  Regulation of eukaryotic protein synthesis by initiation factors. , 1993, The Journal of biological chemistry.

[32]  M. Mathews,et al.  Two RNA-binding motifs in the double-stranded RNA-activated protein kinase, DAI. , 1992, Genes & development.

[33]  M. Katze,et al.  Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. , 1992, Science.

[34]  C. Samuel,et al.  Mechanism of interferon action: identification of a RNA binding domain within the N-terminal region of the human RNA-dependent P1/eIF-2 alpha protein kinase. , 1992, Virology.

[35]  S. Kanner,et al.  CD3-zeta surface expression is required for CD4-p56lck-mediated upregulation of T cell antigen receptor-CD3 signaling in T cells. , 1992, The Journal of biological chemistry.

[36]  O. Elroy-Stein,et al.  The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded-RNA-activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2 , 1992, Journal of virology.

[37]  M. Katze,et al.  Functional expression and characterization of the interferon-induced double-stranded RNA activated P68 protein kinase from Escherichia coli. , 1991, Biochemistry.

[38]  C. Proud,et al.  A synthetic peptide substrate for initiation factor-2 kinases. , 1991, Biochemical and biophysical research communications.

[39]  E. Paoletti,et al.  Vaccinia virus-encoded elF-2α homolog abrogates the antiviral effect of interferon , 1991 .

[40]  C. Samuel,et al.  Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities. , 1991, Virology.

[41]  O. Elroy-Stein,et al.  New mammalian expression vectors , 1990, Nature.

[42]  S. Goebel,et al.  The complete DNA sequence of vaccinia virus. , 1990, Virology.

[43]  I. Kerr,et al.  Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon , 1990, Cell.

[44]  A. Hovanessian.  The double stranded RNA-activated protein kinase induced by interferon: dsRNA-PK. , 1989, Journal of interferon research.

[45]  R. Jagus,et al.  Evaluation of protein phosphorylation state by a combination of vertical slab gel isoelectric focusing and immunoblotting. , 1989, Analytical biochemistry.

[46]  S. Fields,et al.  A novel genetic system to detect protein–protein interactions , 1989, Nature.

[47]  B. Rollins,et al.  Evidence for a novel signal transduction pathway activated by platelet-derived growth factor and by double-stranded RNA , 1989, Molecular and cellular biology.

[48]  R. Saiki,et al.  A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. , 1988, Nucleic acids research.

[49]  T. Hunter,et al.  The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. , 1988, Science.

[50]  A. Hovanessian,et al.  Autophosphorylation of the protein kinase dependent on double-stranded RNA. , 1987, The Journal of biological chemistry.

[51]  H. Schägger,et al.  Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. , 1987, Analytical biochemistry.

[52]  A. Laurent,et al.  Monoclonal antibodies to an interferon-induced Mr 68,000 protein and their use for the detection of double-stranded RNA-dependent protein kinase in human cells. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[53]  M. Clemens.  5 Protein Kinases That Phosphorylate eIF2 and eIF2B, and Their Role in Eukaryotic Cell Translational Control , 1996 .

[54]  R. Jagus,et al.  Proteins that interact with PKR. , 1994, Biochimie.

[55]  M. Katze,et al.  Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[56]  J. Hershey,et al.  Translational control in mammalian cells. , 1991, Annual review of biochemistry.

[57]  R. Pearson,et al.  Design and use of peptide substrates for protein kinases. , 1991, Methods in enzymology.

[58]  R. Pearson,et al.  Pseudosubstrate-based peptide inhibitors. , 1991, Methods in enzymology.